Patient-Reported Outcome in Two Chronic Diseases: A Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma

References

• Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483. doi:10.1097/00005650-199206000-00002
   PubMed Web of Science ®Google Scholar
• Ware JE, Kosinski M, Keller SD. 12-item short-form health survey. Construction of scales and preliminary tests of reliability and validity. Med Care. 1995;34:220–233. doi:10.1097/00005650-199603000-00003
   Web of Science ®Google Scholar
• Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19(8):787–805. doi:10.1097/00005650-198108000-00001
   PubMed Web of Science ®Google Scholar
• Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract. 1985;35(273):185–188.
   PubMedGoogle Scholar
• Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736. doi:10.1007/s11136-011-9903-x
   PubMed Web of Science ®Google Scholar
• Haywood KL, Mars TS, Potter R, Patel S, Matharu M, Underwood M. Assessing the impact of headaches and the outcomes of treatment: a systematic review of patient-reported outcome measures (PROMs). Cephalalgia. 2018;38(7):1374–1386. doi:10.1177/0333102417731348
   Web of Science ®Google Scholar
• Worth A, Hammersley V, Knibb R, et al. Patient-reported outcome measures for asthma: a systematic review. NPJ Prim Care Respir Med. 2014;24:14020. doi:10.1038/npjpcrm.2014.20
   PubMed Web of Science ®Google Scholar
• Martin BC, Pathak DS, Sharfman MI, et al. Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). Headache. 2000;40(3):204–215. doi:10.1046/j.1526-4610.2000.00030.x
   Web of Science ®Google Scholar
• Kosinski M, Bayliss MS, Bjorner JB, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003;12(8):963–974. doi:10.1023/A:1026119331193
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47(2):76–83. doi:10.1136/thx.47.2.76
   PubMed Web of Science ®Google Scholar
• Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65. doi:10.1016/j.jaci.2003.09.008
   PubMed Web of Science ®Google Scholar
• Lyons RA, Lo SV, Littlepage BN. Comparative health status of patients with 11 common illnesses in Wales. J Epidemiol Community Health. 1994;48(4):388–390. doi:10.1136/jech.48.4.388
   Web of Science ®Google Scholar
• Riazi A, Hobart JC, Lamping DL, et al. Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles. J Neurol Neurosurg Psychiatry. 2003;74(6):710–714. doi:10.1136/jnnp.74.6.710
   PubMed Web of Science ®Google Scholar
• Stavem K, Lossius MI, Kvien TK, Guldvog B. The health-related quality of life of patients with epilepsy compared with angina pectoris, rheumatoid arthritis, asthma and chronic obstructive pulmonary disease. Qual Life Res. 2000;9(7):865–871. doi:10.1023/A:1008993821253
   Web of Science ®Google Scholar
• Balieva F, Kupfer J, Lien L, et al. The burden of common skin diseases assessed with the EQ5D: a European multicentre study in 13 countries. Br J Dermatol. 2017;176(5):1170–1178. doi:10.1111/bjd.15280
   PubMed Web of Science ®Google Scholar
• Demoly P, Annunziata K, Gubba E, Adamek L. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev. 2012;21(123):66–74. doi:10.1183/09059180.00008111
   PubMedGoogle Scholar
• Tso AR, Goadsby PJ. Anti-CGRP monoclonal antibodies: the next era of migraine prevention? Curr Treat Options Neurol. 2017;19(8):27. doi:10.1007/s11940-017-0463-4
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Asthma Management and Prevention. Bethesda (USA): National Institutes of Health; 1995.
   Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention. 2006. Available from: http://www.ginashtma.org. Accessed December 17, 2020.
   Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2017. Available from: http://www.ginasthma. Accessed December 17, 2020.
   Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993;4(5):353–365. doi:10.2165/00019053-199304050-00006
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/acp.1983.67.issue-6
   PubMed Web of Science ®Google Scholar
• van Hout B, Janssen MF, Feng YS, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708–715. doi:10.1016/j.jval.2012.02.008
   PubMed Web of Science ®Google Scholar
• Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29. doi:10.1186/1477-7525-1-29
   PubMedGoogle Scholar
• Henry P, Auray JP, Gaudin AF, et al. Prevalence and clinical characteristics of migraine in France. Neurology. 2002;59(2):232–237. doi:10.1212/WNL.59.2.232
   Web of Science ®Google Scholar
• Szende A, Janssen B, Cabasés J. Self-Reported Population Health: An International Perspective Based on EQ-5D. Berlin: Springer Open; 2018.
   Google Scholar
• McClure NS, Sayah FA, Xie F, Luo N, Johnson JA. Instrument-defined estimates of the minimally important difference for EQ-5D-5L index scores. Value Health. 2017;20(4):644–650. doi:10.1016/j.jval.2016.11.015
   PubMed Web of Science ®Google Scholar
• Hernandez G, Garin O, Dima AL, et al. EuroQol (EQ-5D-5L) validity in assessing the quality of life in adults with asthma: cross-sectional study. J Med Internet Res. 2019;21(1):e10178. doi:10.2196/10178
   PubMed Web of Science ®Google Scholar
• Guilbert TW, Garris C, Jhingran P, et al. Asthma that is not well-controlled is associated with increased healthcare utilization and decreased quality of life. J Asthma. 2011;48(2):126–132. doi:10.3109/02770903.2010.535879
   PubMed Web of Science ®Google Scholar
• Mungan D, Aydin O, Mahboub B, et al. Burden of disease associated with asthma among the adult general population of five Middle Eastern countries: results of the SNAPSHOT program. Respir Med. 2018;139:55–64. doi:10.1016/j.rmed.2018.03.030
   PubMed Web of Science ®Google Scholar
• Vo P, Fang J, Bilitou A, Laflamme AK, Gupta S. Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom. J Headache Pain. 2018;19(1):82. doi:10.1186/s10194-018-0907-6
   PubMed Web of Science ®Google Scholar
• Doz M, Chouaid C, Com-Ruelle L, et al. The association between asthma control, health care costs, and quality of life in France and Spain. BMC Pulm Med. 2013;13:15. doi:10.1186/1471-2466-13-15
   PubMed Web of Science ®Google Scholar
• Blumenfeld AM, Varon SF, Wilcox TK, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301–315. doi:10.1177/0333102410381145
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. doi:10.1177/0333102413485658
   PubMed Web of Science ®Google Scholar
• Hennegrave F, Le Rouzic O, Fry S, Behal H, Chenivesse C, Wallaert B. Factors associated with daily life physical activity in patients with asthma. Health Sci Reports. 2018;1(10):e84. doi:10.1002/hsr2.v1.10
   Google Scholar
• Lucas C, Lanteri-Minet M, Massiou H, et al. The GRIM2005 study of migraine consultation in France II. Psychological factors associated with treatment response to acute headache therapy and satisfaction in migraine. Cephalalgia. 2007;27(12):1398–1407. doi:10.1111/j.1468-2982.2007.01446.x
   PubMed Web of Science ®Google Scholar
• Lucas C, Geraud G, Valade D, Chautard MH, Lanteri-Minet M. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey. Headache. 2006;46(5):715–725. doi:10.1111/j.1526-4610.2006.00430.x
   Web of Science ®Google Scholar
• Chalmer MA, Hansen TF, Lebedeva ER, Dodick DW, Lipton RB, Olesen J. Proposed new diagnostic criteria for chronic migraine. Cephalalgia. 2019;333102419877171.
   Web of Science ®Google Scholar